WRN at telomeres: Implications for aging and cancer

Journal of Cell Science

Volumn 120, Issue 5, 2007, Pages 713-721

  Multani, Asha S ^a   Chang, Sandy ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Aging; Cancer; DNA damage; Telomere; Werner syndrome

Indexed keywords

WERNER SYNDROME PROTEIN;

ARTICLE; CANCER; CELLULAR STRESS RESPONSE; DNA DAMAGE; DNA REPLICATION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PREMATURE AGING; PRIORITY JOURNAL; PROTEIN METABOLISM; TELOMERE; WERNER SYNDROME;

AGING; ANIMALS; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; RECQ HELICASES; TELOMERE; WERNER SYNDROME;

MUS;

EID: 34047178427     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.03397     Document Type: Article

References (117)

1. Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W. and Harley, C. B. (1992). Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad Sci. USA 89, 10114-10118.
2. Artandi, S., Chang, S., Lee, S., Alson, S., Gottlieb, G., Chin, L. and Depinho, R. A. (2000). Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645.
3. Bailey, S. M., Brenneman, M. A. and Goodwin, E. H. (2004). Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res. 32, 3743-3751.
4. Baird, D. M., Davis, T., Rowson, J., Jones, C. J. and Kipling, D. (2004). Normal telomere erosion rates at the single cell level in Werner syndrome fibroblast cells. Hum. Mol. Genet. 13, 1515-1524.
5. Bartkova, J., Horejsi, Z., Koed, K., Kramer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C. et al. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870.
6. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, F., Kletsas, D., Issaeva, N., Vassiliou, L. V., Kolettas E., Niforou, K., Zoumpourlis, V. C. et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633-637.
7. Bechter, O. E., Zou, Y., Walker, W., Wright, W. E. and Shay, J. W. (2004). Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res. 64, 3444-3451.
8. Bohr, V. A. (2005). Deficient DNA repair in ale human progeroid disorder, Werner syndrome. Mutat. Res. 577, 252-259.
9. Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S. and Reddel, R. R. (1995). Telomere elongation in immortal human cells without detectable telomemse activity. EMBO J 14, 4240-4248.
10. Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A. and Reddel, R. R. (1997). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3, 1271-1274.
11. Campisi, J. (2005). Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522.
12. Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A. and Kerber, R. A. (2003). Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361, 393-395.
13. Celli, G. B. and de Lange, T. (2005). DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 7, 712-718.
14. Celli, G. B., Denchi, E. L. and de Lange, T. (2006). Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous-recombination. Nat. Cell Biol. 8, 885-890.
15. Cerone, M. A., Londono-Vallejo, J. A. and Bacchetti, S. (2001). Telomere maintenance by telomerase and by recombination can coexist in human cells. Hunt. Mol. Genet. 10, 1945-1952.
16. Chang, S., Khoo, C. M., Naylor, M. L., Maser, R. S. and DePinho, R. A. (2003). Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev. 17, 88-100.
17. Chang, S., Multani, A. S., Cabrera, N. G., Naylor, M. L., Laud, P., Lombard, D., Pathak, S., Guarente, L. and DePinho, R. A. (2004). Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat. Genet. 36, 877-882.
18. Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W. L., Ljung, B. M., Chew, K., Myambo, K. et al. (2004). In situ analyses of genome instability in breast cancer. Nat. Genet. 36, 984-988.
19. Choi, D., Whittier, P. S., Oshima, J. and Funk, W. D. (2001). Telomerase expression prevents repticative senescence but does not fully reset mRNA expression patterns in Werner syndrome cell strains. FASEB J. 15, 1014-1020.
20. Cohen, H. and Sinclair, D. A. (2001). Recombination-mediated lengthening of terminal telomeric repeats requires the Sgs1 DNA helicase. Proc. Natt. Acad Sci. USA 98, 3174-3179.
21. Comai, L. and Li, B. (2004). The Wenner syndrome protein at the crossroads of DNA repair and apoptosis. Mech Ageing Dev. 125, 521-528.
22. Constantinou, A., Tarsounas, M., Karow, J. K., Brosh, R. M., Bohr, V. A., Hickson, I. D. and West, S. C. (2000). Wenner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep. 1, 80-84.
23. Cooper, M. P., Machwe, A., Orren, D. K., Brosh, R. M., Ramsden, D. and Bohr, V. A. (2000). Ku complex interacts with and stimulates the Werner protein. Genes Dev. 14, 907-912.
24. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B. and Bacchetti, S. (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929.
25. Crabbe, L., Verdun, R. E., Haggblom, C. I. and Karlseder, J. (2004). Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306, 1951-1953.
26. Crabbe, L., Jaunch, A., Naegar, C. M., Holtgreve-Grez, H. and Karlseder, J. (2007). Telomere dysfunction as a cause of genomic instability in Werner Syndrome. Proc. Natl. Acad. Sci. USA In press.
27. d'Adda di Fagagna, F., Hande, M. P., Tong, W. M., Roth, D., Lansdorp, F. M., Wang, Z. Q. and Jackson, S. P. (2001). Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11, 1192-1196.
28. d'Adda di Fagagna, F., Reaper, P. M., Clay-Farrace, L., Flegler, H., Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N. F. and Jackson, S. F. (2003). A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198.
29. d'Adda di Fagagna, R, Teo, S. H. and Jackson, S. F. (2004). Functional links between telomeres and proteins of the DNA-damage response. Genes Dev. 18, 1781-1799.
30. Davis, T., Baird, D. M, Haughton, M. E, Jones, C. J. and Kipling, D. (2005). Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. J. Gerontol. A Biol. Sci Med. Sci. 60, 1386-1393.
31. de Lange, T. (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100-2110.
32. Di Micco, R., Fumagalli, M., Cicalese, A., Piccini, S., Gasparini, P., Luise, C., Schurra, C., Garre' M., Nuciforo P. G., Bensimon A. et al. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642.
33. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I, Pereira-Smith, O. et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363-9367.
34. Du, X., Shen, J., Kugan, N., Furth, E., Lombard, D., Cheung, C., Pak, S., Luo, G., Pignolo, R., DePinho, R. A. et al. (2004). Telomere shortening exposes functions for the Werner and Bloom syndrome genes in mice. Mol. Cell. Biol. 24, 8437-8446.
35. Epstein, C. J., Martin, G. M., Schultz, A. L. and Motulsky, A. G. (1966). Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine Baltimore 45, 177-221.
36. Faragher, R. G., Kill, I. R., Hunter, J. A., Pope, F. M., Tannock, C. and Shall, S. (1993). The gene responsible for Werner syndrome may be a cell division "counting" gene. Proc. Natl. Acad. Sci. USA 90, 12030-12034.
37. Fasching, C. L., Bower, K. and Reddel, R. R. (2005). Telomere-independent telomere length-maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. Cancer Res. 65, 2722-2729.
38. Gorgoulis, V. G., Vassiliou, L. V., Karakaidos, P., Zacharatos, F., Kotsinas, A., Liloglou, T., Venere, M., Ditullio, R. A., Jr, Kastrinakis, N. G., Levy, B. et al. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913.
39. Goto, M., Miller, R. W., Ishikawa, Y. and Sugano, H. (1996). Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol. Biomarkers Prev. 5, 239-246.
40. Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H. and de Lange, T. (1999). Mammalian telomeres end in a large duplex loop. Cell 97, 503-514.
41. Hara, E., Tsurui, H., Shinozaki, A., Nakada, S. and Oda, K. (1991). Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179, 528-534.
42. Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M. and Grelder, C. W. (1994). Telomemse, cell immamortality, and cancer. Cold Spring Harb. Symp. Quant. Biol. 59, 307-315.
43. Hayflick, L. (1965). The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636.
44. Hemann, M. T., Strong, M. A., Hao, L. Y. and Grelder, C. W. (2001). The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67-77.
45. Henson, J. D., Neumann, A. A., Yeager, T. R. and Reddel, R. R. (2002). Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610.
46. Herbig, U., Ferreira, M., Condel, L., Carey, D. and Sedivy, J. M. (2006). Cellular senescence in aging primates. Science 311, 1257.
47. Hickson, I. D. (2003). RecQ helicases: caretakers of the genome. Nat. Rev. Cancer 3, 169-178.
48. Hockemeyer, D., Daniels, J. P., Takai, H. and de Lange, T. (2006). Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 126, 63-77.
49. Hsu, H. L., Gilley, D., Blackburn, E. H. and Chen, D. J. (1999). Ku is associated with the telomere in mammals. Proc. Natl. Acad. Sci. USA 96, 12454-12458.
50. Hsu, H. L., Gilley, D., Galande, S. A., Hande, M. P., Allen, B., Kim, S. H., Li, G. C., Campisi, J., Kohwi-Shigematsu, T. and Chen, D. J. (2000). Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev. 14, 2807-2812.
51. Huang, P., Pryde, F. E., Lester, D., Maddison, R. L., Borts, R. H., Hickson, I. D. and Louis, E. J. (2001). SGS1 is required for telomere elongation in the absence of telomerase. Curr. Biol. 11, 125-129.
52. Itahana, K., Dimri. G. and Campisi, J. (2001). Regulation of cellular senescence by p53. Eur. J. Biochem. 268, 2784-2791.
53. Iwasa, H., Han, J. and Ishikawa, R (2003). Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8, 131-144.
54. Jacobs, J. J. and de Lange, T. (2004). Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr Biol. 14, 2302-2308.
55. Johnson, F. B., Marciniak, R. A., McVey, M., Stewart, S. A., Hahn, W. C. and Guarente, L. (2001). The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J. 20, 905-913.
56. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. and de Lange, T. (1999). p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-1325.
57. Karmakar, F., Snowden, C. M., Ramsden, D. A. and Bohr, V. A. (2002). Ku heterodimer binds to both ends of the Werner protein and functional interaction occurs at the Werner N-terminus. Nucleic Acids Res. 30, 3583-3591.
58. Kelleher, C., Kurth, L and Lingner, J. (2005). Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol. Cell. Biol. 25, 808-818.
59. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L. and Shay, J. W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
60. Kim, S. H., Beausejour, C., Davalos, A. R., Kaminker, P., Heo, S. J. and Campisi, J. (2004). TIN2 mediates functions of TRF2 at human telomeres. J. Biol. Chem. 279, 43799-43804.
61. Krtolica, A. and Campisi, J. (2002). Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int. J. Biochem. Cell Biol. 34, 1401-1414.
62. Laud, P. R., Multani, A. S., Bailey, S. M., Wu, L., Ma, J., Kingsley, C., Lebel, M., Pathak, S., DePinho, R. A. and Chang, S. (2005). Elevated telomere-telomere recombination in WTN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev. 19, 2560-2570.
63. LeBel, C. and Wellinger, R. J. (2005). Telomeres: what's new at your end? J. Cell Sci. 118, 2785-2788.
64. Lei, M., Podell, E. R. and Cech, T. R. (2004). Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat. Struct. Mol. Biol. 11, 1223-1229.
65. Lei, M., Zaug, A. J., Podell, E. R. and Cech, T. R. (2005). Switching human telomerase on and off with hPOT1 protein in vitro. J Biol. Chem. 280, 20449-20456.
66. Li, B. and Comai, L. (2000). Functional interaction between Ku and the werner syndrome protein in DNA end processing. J. Biol. Chem. 275, 39800-39807.
67. Liu, D., Safari, A., O'Connor, M. S., Chan, D. W., Laegeler, A., Qin, J. and Songyang, Z. (2004a). PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell Biol. 6, 673-680.
68. Liu, D., O'Connor, M. S., Qin, J. and Songyang, Z. (2004b). Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J. Biol. Chem. 279, 51338-51342.
69. Loayza, D. and de Lange, T. (2003). POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 1013-1018.
70. Lombard, D. B., Beard, C., Johnson, B., Marciniak, R. A., Dausman, J., Bronson R. Buhlmann, J. E., Lipman, R., Curry, R., Sharpe, A. et al. (2000). Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol. Cell. Biol. 20, 3286-3291.
71. Londono-Vallejo, J. A., Der-Sarkissian, H., Cazes, L., Bacchetti, S. and Reddel, R. R. (2004). Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res. 64, 2324-2327.
72. Machme, A., Xiao, L. and Orren, D. K. (2004). TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA. Oncogene 23, 149-156.
73. Marciniak, R. A., Cavazos, D., Montellano, R., Chen, Q., Guarente, L. and Johnson, F. B. (2005). A novel telomere structure in a human alternative lengthening of telomeres cell line. Cancer Res. 65, 2730-2737.
74. Martin, G. M. and Oshima, J. (2000). Lessons from human progeroid syndromes. Nature 408, 263-266.
75. Martin, G. M., Sprague, C. A. and Epstein, C. J. (1970). Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab. Invest. 23, 86-92.
76. Maser, R. S. and DePinho, R. A. (2004). Telomeres and the DNA damage response: why the fox is guarding the henhouse. DNA Repair Amst. 3, 979-988.
77. Melcher, R., von Golitschek. R., Steinlein, C., Schindler, D., Neitzel, H., Kainer, K., Schmid, M. and Hoehn, H. (2000). Spectral karyotyping of Werner syndrome fibroblast cultures. Cytogenet. Cell Genet. 91, 180-185.
78. Mohaghegh, P., Karow, J. K., Brosh, R. M., Jr, Bohr, V. A. and Hickson, I. D. (2001). The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res. 29, 2843-2849.
79. Muntoni, A. and Reddel, R. R. (2005). The first molecular details of ALT in human tumor cells. Hum. Mol. Genet. 14, R191-196.
80. Murti, K. G. and Prescott, D. M. (1999). Telomeres of polytene chromosomes in a ciliated protozoan terminate in duplex DNA loops. Proc. Natl. Acad. Sci. USA 96, 14436-14439.
81. Myung, K., Datta, A., Chen, C. and Kolodner, R. D. (2001). SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination. Nat. Genet. 27, 113-116.
82. Niida, H., Shinkai, Y., Hande, M. P., Matsumoto, T., Takehara, S., Tachibana, M., Oshimura, M., Lansdorp, F. M. and Furuichi, Y. (2000). Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol. Cell. Biol. 20, 4115-4127.
83. O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L. and DePinho, R. A. (2002). Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2, 149-155.
84. Opresko, P. L., von Kobbe, C., Laine, J. P., Harrigan, J., Hickson, I. D. and Bohr, V, A. (2002). Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J. Biol. Chem. 277, 41110-41119.
85. Opresko, P, L., Otterlei, M., Graakjaer, J., Bruheim, P., Dawut, L., Kolvraa, S., May, A., Seidman, M. M. and Bohr, V. A. (2004). The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol. Cell 14, 763-774.
86. Opresko, F. L., Mason, P. A., Podell, E. R., Lei, M., Hickson, I. D., Cech, T. R. and Bohr, V. A. (2005). POT1 stimulates recQ helicases WRN and BLM to unwind telomeric DNA substrates. J. Biol. Chem. 280, 32069-32080.
87. Orren, D. K. (2006). Werner syndrome: molecular insights into the relationships between defective DNA metabolism, genomic instability, cancer and aging. Front. Biosci. 11, 2657-2671.
88. Orren, D. K., Machwe, A., Karmakar, F., Piotrowski, J., Cooper, M. F. and Bohr, V. A. (2001). A functional interaction of Ku with Wenner exonuclease facilitates digestion of damaged DNA. Nucleic Acids Res. 29, 1926-1934.
89. Perrem, K., Colgin, L. M., Neumann, A. A., Yeager, T. R. and Reddet, R. R. (2001). Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21, 3862-3875.
90. Pichierri, F., Franchitto, A., Mosesso, P. and Palitti, R (2001). Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle. Mol. Biol. Cell 12, 2412-2421.
91. Pont, M., Hoehn, H., Runger, T. M. and Martin, G. M. (1992). Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp. Cell Res. 202, 267-273.
92. Riha, K., Heacock, M. L. and Shippen, D. E. (2006). The role of the nonhomologous end-joining DNA double-strand break repair pathway in telomere biology. Annu. Rev. Genet. 40, 237-277.
93. Rudolph, K. L, Chang, S., Lee, H. W., Blasco, M., Gottlieb, G. J., Greider, C. and DePinho, R. A. (1999). Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712.
94. Salk, D., Au, K., Hoehn, H. and Martin, G. M. (1981). Cytogenetics of Werner's syndrome cultured skin fibroblasts: variegated translocation mosaicism. Cytogenet. Cell Genet. 30, 92-107.
95. Schmitt, C. A. (2003). Senescence apoptosis and therapy-cutting the lifelines of cancer. Nat. Rev. Cancer 3, 286-295.
96. Sharpless, N. E. and DePinho, R. A. (2004). Telomeres stem cells senescence and cancer. J. Clin. Invest. 113, 160-168.
97. Shay, J. W. and Bacchetti, S. (1997). A survey of telomerase activity in human cancer. Eur J Cancer 33, 787-791.
98. Shay, J. W., Pereira-Smith, O.M. and Wright, W. E. (1991). A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196, 33-39.
99. Smogorzewska, A. and de Lange, T. (2004). Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73, 177-208.
100. Sugawara, N., Goldfarb, T., Studamire, B., Alani, E. and Haber, J. E. (2004). Heteroduplex rejection during single-strand annealing requires Sgs1 helicase and mismatch repair proteins Msh2 and Msh6 but not Pms1. Proc. Natl. Acad Sci. USA 101, 9315-9320.
101. Szekely, A. M., Bleichert, E, Numann, A., Van Komen, S., Manasanch, E., Ben Nasr, A., Canaan, A. and Weissman, S. M. (2005). Werner protein protects nonproliferating cells from oxidative DNA damage. Mol. Cell. Biol. 25, 10492-10506.
102. Takai, H., Smogorzewska, A. and de Lange, T. (2003). DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549-1556.
103. Teng, S. C., Chang, J., McCowan, B. and Zakian, V. A. (1999). Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad.50p-dependent, Rif-inhibited recombinational process. Mol. Cell 6, 947-952.
104. Thannhauser, S. J. (1945). Werner's syndrome (progeria of the adult) and Rothmund's syndrome: two types of closely related heredofamilial atrophic dermatosis with juvenile cataracts and endocrine features. A critical study with five new cases. Ann. Intern. Med. 23, 559-625.
105. van Steensel, B. and de Lange, T. (1997). Control of telomere length by the human telomeric protein TRF1. Nature 385, 740-743.
106. van Steensel, B., Smogorzewska, A. and de Lange, T. (1998). TRF2 protects human telomeres from end-to-end fusions. Cell 92, 401-413.
107. Vasile, E., Tomita, Y., Brown, L. F., Kocher, O. and Dvorak, H. F. (2001). Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 15, 458-466.
108. Veldman, T., Etheridge, K. T. and Counter, C. M. (2004). Loss of hPot1 function leads to telomere instability and a cut-like phenotype. Curr. Biol. 14, 2264-2270.
109. Wong, K. K., Chang, S. and Depinho, R. A. (2006). Modeling cancer and aging in the telomerase-deficient mouse. In Telomeres (ed. T. de Lange, V. Lundblad and E. Blackburn), pp. 109-138. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
110. Wright, W. E. and Shay, J. W. (1992). The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27, 383-389.
111. Wright, W. E. and Shay, J. W. (1995). Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism? Trends Cell Biol. 5, 293-297.
112. Wu, L., Multani, A. S., He, H., Cosme-Blanco, W., Deng, Y., Deng, J. M., Bachilo, O., Pathak, S., Tahara, H., Bailey, S. M. et al. (2006). Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell. 126, 49-62.
113. Wyllie, F. S., Jones, C. J., Skinner, J. W., Haughton, M. R, Wallis, C., Wynford-Thomas, D., Faragher, R. G. and Kipting, D. (2000). Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24, 16-17.
114. Yang, Q. Zheng, Y. L. and Harris, C. C. (2005). POT1 and TRF2 cooperate to maintain telomeric integrity. Mol. Cell. Biol. 25, 1070-1080.
115. Ye, J. Z., Hockemeyer, D., Krutchinsky, A. N., Loayza, D., Hooper, S. M., Chait, B. T. and de Lange, T. (2004). POT1 -interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 18, 1649-1654.
116. Zaug, A. J., Podell, E. R. and Cech, T. R. (2005). Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. Proc. Natl. Acad. Sci. USA 102, 10864-10869.
117. Zhang, N., Kaur, R., Lu, X., Shen, X., Li, L. and Legerski, R. J. (2005). The Pso4 mRNA splicing and DNA repair complex interacts with WRN for processing of DNA interstrand cross-links. J. Biol. Chen 280, 40559-40567.